Sign in

CIK 0000109657

  • Non-accelerated filer
  • Smaller reporting company

GT Biopharma, Inc.

Sign in to watch
Ticker
GTBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
941620407
Phone
+1 800-304-9888
Business address
505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
Former names
GT Biopharma, Inc., OXIS INTERNATIONAL INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-09-04 URBAN ALAN LOUIS Chief Financial Officer Grant or award · Option to purchase Common Stock +50,000 50,000
2025-09-04 URBAN ALAN LOUIS Chief Financial Officer Grant or award · Option to purchase Common Stock +50,000 50,000
2025-09-04 Mun-Gavin David C. Director Grant or award · Option to purchase Common Stock +31,250 31,250
2025-09-04 Kramer Hilary Director Grant or award · Option to purchase Common Stock +31,250 31,250
2025-09-04 CASAMENTO CHARLES J Director Grant or award · Option to purchase Common Stock +62,500 62,500
2025-09-04 Breen Michael Martin CEO and Director Grant or award · Option to purchase Common Stock +100,000 100,000
2025-09-04 Breen Michael Martin CEO and Director Grant or award · Option to purchase Common Stock +100,000 100,000
2025-09-04 Breen Michael Martin CEO and Director Grant or award · Option to purchase Common Stock +100,000 100,000
2024-10-17 URBAN ALAN LOUIS Chief Financial Officer Grant or award · Option to purchase Common Stock +23,335 23,335
2023-08-11 Breen Michael Martin Executive Chairman/Interim CEO Grant or award +200,000 $0.29 $57K 856,218
2023-08-11 Ohri Manu CFO & Secretary Grant or award +200,000 $0.29 $57K 200,000
2023-08-11 Ohri Manu CFO & Secretary Other disposition −200,000 $0.29 $57K 0
2023-08-11 Ohri Manu CFO & Secretary Other acquisition +200,000 $0.29 $57K 300,000
2023-06-16 CASAMENTO CHARLES J Director Grant or award · Option to purchase Common Stock +500,000 500,000
2023-04-11 Breen Michael Martin Executive Chairman/Interim CEO Purchase +50,000 $0.50 $25K 656,218
2023-04-06 Ohri Manu CFO & Secretary Purchase +50,000 $0.50 $25K 50,000
2023-01-27 Breen Michael Martin Exec Chairman and Interim CEO Grant or award · Option to purchase Common Stock +500,000 500,000
2023-01-27 Ohri Manu Chief Financial Officer Grant or award · Option to purchase Common Stock +500,000 500,000
2023-01-27 SHROTRIYA RAJESH C MD Director Grant or award · Option to purchase Common Stock +500,000 500,000
2023-01-27 Wendel Bruce Director Grant or award · Option to purchase Common Stock +500,000 500,000

Page 1 of 9 · 178 trades